Viewing nowAlfshin XL Tablet (Alfuzosin Hydrochloride)
Alfuzosin Hydrochloride 5mg
Tablet · Prescription medication
Korea Pharmaceutical Co., Ltd.

MFDS item code 200708586 · Notified 2007.07.25 · Insurance code 642800970
Treatment of symptoms of benign prostatic hyperplasia; adjunctive use with a catheter in cases of associated acute urinary retention
This medication is used to treat functional symptoms associated with urinary disorders caused by benign prostatic hyperplasia. Additionally, it serves as an auxiliary treatment when acute urinary retention occurs and catheterization is required. In other words, it helps alleviate various symptoms related to prostatic hyperplasia and supports therapeutic effects.
The recommended dose is 10mg once daily, taken immediately after the evening meal. Do not chew; swallow the tablet whole. When administered as adjunctive therapy to catheterization for acute urinary retention associated with benign prostatic hyperplasia, the recommended dose is 10mg once daily, taken after a meal starting on the first day of catheterization. Take for 2-3 days while the catheter is in place and for 1 day after catheter removal, for a total of 3-4 days.
This medication belongs to the class of alpha-blockers and should not be administered to certain patients. For example, patients with allergies to this medication or its components, patients with orthostatic hypotension, patients with severely impaired liver function, patients with very poor kidney function, patients with bowel obstruction, patients already taking other alpha-blockers, and patients taking potent CYP3A4 inhibitors should not be administered this medication. Some patients, particularly those treated for hypertension, may experience orthostatic hypotension within a few hours following initial dosing. Symptoms such as dizziness, fatigue, and sweating may occur, so it is advisable to lie down and rest when such symptoms arise. Older patients are more susceptible to these side effects, thus caution is necessary. Patients exhibiting symptoms of orthostatic hypotension or those taking antihypertensive agents or nitrate preparations should be administered this medication cautiously. It should not be used alone in patients with coronary artery disease, and if symptoms of angina worsen, administration should be halted immediately. Additionally, caution should be exercised in patients with congenital or acquired QT interval prolongation or those taking medications that prolong the QT interval. During treatment with this medication, side effects such as dizziness, headache, nausea, abdominal pain, constipation, fatigue, and weakness may commonly occur. Rarely, serious side effects such as worsening of heart disease, skin rashes, and thrombocytopenia may occur, and if any abnormal symptoms appear, it is essential to consult a physician immediately. This medication can cause a rare complication known as 'intraoperative floppy iris syndrome' in patients scheduled for cataract surgery; therefore, it is crucial to inform the attending ophthalmologist about taking this medication before the surgery. When swallowing the tablets, do not crush or chew them, but swallow them whole; crushing or making them into powder can cause rapid drug action and may lead to excessive drops in blood pressure. This medication may cause a rare side effect known as priapism, which, if untreated, can lead to permanent erectile dysfunction, so it is imperative to inform medical personnel immediately if symptoms occur. When taken with certain antihypertensive agents or potent CYP3A4 inhibitors, the hypotensive effect may be excessively increased or drug concentration may rise, so patients must inform their physician or pharmacist about any currently taken medications. The safety of this medication during pregnancy or breastfeeding has not been established, and it is not intended for use in pediatric patients. Dizziness or weakness may occur early in treatment with this medication, so caution should be exercised while driving or operating hazardous machinery. In case of overdose, hospitalization and appropriate treatment are necessary; this medication is difficult to remove by blood dialysis. Finally, this medication should be kept out of reach of children and should not be transferred to another container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container, protected from air and moisture, and maintained at room temperature between 1 degree and 30 degrees Celsius. By storing it this way, the effectiveness of the medication can be preserved for a longer period.
This medication is a film-coated tablet with a total of three layers, consisting of one white layer sandwiched between two yellow layers, shaped as a biconvex round tablet.
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAlfuzosin Hydrochloride 5mg
Tablet · Prescription medication
Korea Pharmaceutical Co., Ltd.

Alfuzosin Hydrochloride 10mg
Tablet · Prescription medication
Handok Co., Ltd.

Alfuzosin Hydrochloride 5mg
Tablet · Prescription medication
Ahn-Gook Pharmaceutical Co., Ltd.

Alfuzosin Hydrochloride 5mg
Tablet · Prescription medication
Dongkwang Pharmaceutical Co., Ltd.

Alfuzosin Hydrochloride 5mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Alfuzosin Hydrochloride 5mg
Tablet · Prescription medication
HK inno.N Co., Ltd.

Alfuzosin Hydrochloride 5mg
Tablet · Prescription medication
Bionex Co., Ltd.

Alfuzosin Hydrochloride 5mg
Tablet · Prescription medication
FarmGen Science Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.